Controversies in Internal Medicine
April 28, 2008

Mandated Diabetes Registries Will Not Benefit Persons With Diabetes

Author Affiliations

ANN B.NATTINGERMD, MPHAuthor Affiliations:Departments of Psychiatry and Medicine, State University of New York (SUNY) Upstate Medical University, Syracuse (Dr Trief); and College of Law, Syracuse University, Syracuse (Dr Ellison).


Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008

Arch Intern Med. 2008;168(8):799-802. doi:10.1001/archinte.168.8.799

This past year, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has embarked on a radical new approach to improving the care of patients with diabetes. Following the lead of a similar program in Vermont,1they have established a mandatory registry of diabetic patients and their hemoglobin A1c(HbA1c) values. Hemoglobin A1cis a reliable measure of blood glucose control over the preceding 2 to 3 months.2Good glycemic control (ie, HbA1clevel <7.0%) is the goal patients and physicians work toward, since it has been convincingly demonstrated that good glycemic control can forestall and prevent diabetes-related complications.3,4Diabetes registries have been used for many years to track and research the disease. However, this registry is different from those commonly used. In the NYC and Vermont registries, information is gathered about the patient without their explicit informed consent, using a passive opt-out procedure. We believe that this approach will be ineffective, will undermine the physician-patient relationship and the expectation of medical privacy, is ethically compromised, and could be dangerous; thus, we take the position against the establishment of such a registry.

First Page Preview View Large
First page PDF preview
First page PDF preview